Pages that link to "Q92967590"
Jump to navigation
Jump to search
The following pages link to Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database (Q92967590):
Displaying 26 items.
- The roles of glucose metabolic reprogramming in chemo- and radio-resistance (Q64282716) (← links)
- Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition) (Q89497183) (← links)
- Incorrect Bars in Graph Showing Gene Mutations (Q89521737) (← links)
- Fall in US cancer death rates: Time to pop the champagne? (Q89561241) (← links)
- Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer (Q89690066) (← links)
- A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants (Q89967608) (← links)
- Blockchain-Authenticated Sharing of Genomic and Clinical Outcomes Data of Patients With Cancer: A Prospective Cohort Study (Q90503929) (← links)
- Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer (Q90612116) (← links)
- Precision Medicine 2030 (Q91539450) (← links)
- Pan-Cancer Analysis of CDK12 Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype (Q91775939) (← links)
- An annual review of the remarkable advances in lung cancer clinical research in 2019 (Q91793281) (← links)
- Precision medicine for human cancers with Notch signaling dysregulation (Review) (Q92366436) (← links)
- Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types (Q92512470) (← links)
- An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies (Q92602032) (← links)
- Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab (Q92684921) (← links)
- Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis (Q92778091) (← links)
- Our best weapons against cancer are not magic bullets (Q92825804) (← links)
- The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma (Q93016463) (← links)
- Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas (Q93078485) (← links)
- Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28 (Q96304660) (← links)
- [Chinese Expert Consensus on Next Generation Sequencing Diagnosis for Non-small Cell Lung Cancer (2020 Edition)] (Q99590522) (← links)
- Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors (Q99630568) (← links)
- Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity (Q100694062) (← links)
- Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells (Q101136382) (← links)
- Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients (Q101216847) (← links)
- Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma (Q103020991) (← links)